pharmaceutical investing ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872
SAGA Metals Reports Final Titanium, Vanadium and Iron Assays from MRE Drilling--Maiden Mineral Resource Estimate Imminent